Raymond James & Associates’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-14,720
| Closed | -$50K | – | 3570 |
|
|
2020
Q2 | $50K | Buy |
+14,720
| New | +$50K | ﹤0.01% | 3321 |
|
|
2019
Q3 | – | Sell |
-12,305
| Closed | -$167K | – | 3596 |
|
|
2019
Q2 | $167K | Buy |
12,305
+2,175
| +21% | +$29.5K | ﹤0.01% | 3290 |
|
|
2019
Q1 | $55K | Sell |
10,130
-1,336
| -12% | -$7.25K | ﹤0.01% | 3420 |
|
|
2018
Q4 | $34K | Sell |
11,466
-7,200
| -39% | -$21.4K | ﹤0.01% | 3373 |
|
|
2018
Q3 | $152K | Buy |
18,666
+1,796
| +11% | +$14.6K | ﹤0.01% | 3332 |
|
|
2018
Q2 | $164K | Buy |
+16,870
| New | +$164K | ﹤0.01% | 3296 |
|